FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3090758030> ?p ?o ?g. }

• W3090758030 abstract "Abstract Efforts to mitigate COVID-19 include screening of existing antiviral molecules that could be re-purposed to treat SARS-CoV-2 infections. Although SARS-CoV-2 propagates efficiently in African green monkey kidney (Vero) cells, antivirals such as nucleos(t)ide analogs (nucs) often exhibit decreased activity in these cells due to inefficient metabolization. Limited SARS-CoV-2 replication and propagation occurs in human cells, which are the most relevant testing platforms. By performing serial passages of a SARS-CoV-2 isolate in the human hepatoma cell line clone Huh7.5, we selected viral populations with improved viability in human cells. Culture adaptation led to the emergence of a significant number of high frequency changes (>90% of the viral population) in the region coding for the spike glycoprotein, including a deletion of nine amino acids in the N-terminal domain and 3 amino acid changes (E484D, P812R, and Q954H). We demonstrated that the Huh7.5-adapted virus exhibited a >3-Log 10 increase in infectivity titers (TCID 50 ) in Huh7.5 cells, with titers of ~8 Log 10 TCID 50 /mL, and >2-Log 10 increase in the human lung cancer cell line Calu-1, with titers of ~6 Log 10 TCID 50 /mL. Culture adaptation in Huh7.5 cells further permitted efficient infection of the otherwise SARS-CoV-2 refractory human lung cancer cell line A549, with titers of ~6 Log 10 TCID 50 /mL. The enhanced ability of the virus to replicate and propagate in human cells permitted screening of a panel of nine nucs, including broad-spectrum compounds. Remdesivir, EIDD-2801 and to a limited extent galidesivir showed antiviral effect across these human cell lines, whereas sofosbuvir, uprifosbuvir, valopicitabine, mericitabine, ribavirin, and favipiravir had no apparent activity. Importance The cell culture adapted variant of the SARS-CoV-2 virus obtained in the present study, showed significantly enhanced replication and propagation in various human cell lines, including lung derived cells otherwise refractory for infection with the original virus. This SARS-CoV-2 variant will be a valuable tool permitting investigations across human cell types, and studies of identified mutations could contribute to our understanding of viral pathogenesis. In particular, the adapted virus can be a good model for investigations of viral entry and cell tropism for SARS-CoV-2, in which the spike glycoprotein plays a central role. Further, as shown here with the use of remdesivir and EIDD-2801, two nucs with significant inhibitory effect against SARS-CoV-2, large differences in the antiviral activity are observed depending on the cell line. Thus, it is essential to select the most relevant target cells for pre-clinical screenings of antiviral compounds, facilitated by using a virus with broader tropism." @default.
• W3090758030 created "2020-10-08" @default.
• W3090758030 creator A5000807185 @default.
• W3090758030 creator A5031709092 @default.
• W3090758030 creator A5031824210 @default.
• W3090758030 creator A5038234181 @default.
• W3090758030 creator A5044969044 @default.
• W3090758030 creator A5065447488 @default.
• W3090758030 creator A5066391487 @default.
• W3090758030 creator A5068215994 @default.
• W3090758030 creator A5072444606 @default.
• W3090758030 creator A5073835639 @default.
• W3090758030 date "2020-10-04" @default.
• W3090758030 modified "2023-09-30" @default.
• W3090758030 title "Efficient culture of SARS-CoV-2 in human hepatoma cells enhances viability of the virus in human lung cancer cell lines permitting the screening of antiviral compounds" @default.
• W3090758030 cites W1965531501 @default.
• W3090758030 cites W1967785127 @default.
• W3090758030 cites W1980805512 @default.
• W3090758030 cites W1986041794 @default.
• W3090758030 cites W1987263725 @default.
• W3090758030 cites W1997944527 @default.
• W3090758030 cites W2001497336 @default.
• W3090758030 cites W2009987166 @default.
• W3090758030 cites W2036897871 @default.
• W3090758030 cites W2070647602 @default.
• W3090758030 cites W2071467437 @default.
• W3090758030 cites W2083525619 @default.
• W3090758030 cites W2092064675 @default.
• W3090758030 cites W2097546936 @default.
• W3090758030 cites W2106118844 @default.
• W3090758030 cites W2106967530 @default.
• W3090758030 cites W2117960515 @default.
• W3090758030 cites W2124250444 @default.
• W3090758030 cites W2128185278 @default.
• W3090758030 cites W2132926880 @default.
• W3090758030 cites W2150368001 @default.
• W3090758030 cites W2156639337 @default.
• W3090758030 cites W2160788656 @default.
• W3090758030 cites W2167384912 @default.
• W3090758030 cites W2167490988 @default.
• W3090758030 cites W2168280552 @default.
• W3090758030 cites W2177482530 @default.
• W3090758030 cites W2495212599 @default.
• W3090758030 cites W2520100414 @default.
• W3090758030 cites W2564443324 @default.
• W3090758030 cites W2606148195 @default.
• W3090758030 cites W2797613160 @default.
• W3090758030 cites W2883834853 @default.
• W3090758030 cites W2906702017 @default.
• W3090758030 cites W2939518231 @default.
• W3090758030 cites W2945440984 @default.
• W3090758030 cites W2981723136 @default.
• W3090758030 cites W2991889508 @default.
• W3090758030 cites W2995902735 @default.
• W3090758030 cites W3001195213 @default.
• W3090758030 cites W3008443627 @default.
• W3090758030 cites W3009906937 @default.
• W3090758030 cites W3009912996 @default.
• W3090758030 cites W3010955108 @default.
• W3090758030 cites W3014203610 @default.
• W3090758030 cites W3014708904 @default.
• W3090758030 cites W3015472194 @default.
• W3090758030 cites W3016829967 @default.
• W3090758030 cites W3017302293 @default.
• W3090758030 cites W3021183041 @default.
• W3090758030 cites W3021253909 @default.
• W3090758030 cites W3022722383 @default.
• W3090758030 cites W3027918021 @default.
• W3090758030 cites W3029393188 @default.
• W3090758030 cites W3033802766 @default.
• W3090758030 cites W3036391214 @default.
• W3090758030 cites W3036749055 @default.
• W3090758030 cites W3037578804 @default.
• W3090758030 cites W3039901154 @default.
• W3090758030 cites W3040801404 @default.
• W3090758030 cites W3041968020 @default.
• W3090758030 cites W3043263509 @default.
• W3090758030 cites W3044722686 @default.
• W3090758030 cites W3045003495 @default.
• W3090758030 cites W3081204841 @default.
• W3090758030 cites W3081250216 @default.
• W3090758030 doi "https://doi.org/10.1101/2020.10.04.325316" @default.
• W3090758030 hasPublicationYear "2020" @default.
• W3090758030 type Work @default.
• W3090758030 sameAs 3090758030 @default.
• W3090758030 citedByCount "6" @default.
• W3090758030 countsByYear W30907580302020 @default.
• W3090758030 countsByYear W30907580302021 @default.
• W3090758030 countsByYear W30907580302023 @default.
• W3090758030 crossrefType "posted-content" @default.
• W3090758030 hasAuthorship W3090758030A5000807185 @default.
• W3090758030 hasAuthorship W3090758030A5031709092 @default.
• W3090758030 hasAuthorship W3090758030A5031824210 @default.
• W3090758030 hasAuthorship W3090758030A5038234181 @default.
• W3090758030 hasAuthorship W3090758030A5044969044 @default.
• W3090758030 hasAuthorship W3090758030A5065447488 @default.
• W3090758030 hasAuthorship W3090758030A5066391487 @default.
• W3090758030 hasAuthorship W3090758030A5068215994 @default.
• W3090758030 hasAuthorship W3090758030A5072444606 @default.
• W3090758030 hasAuthorship W3090758030A5073835639 @default.

• next